194 filings
Page 2 of 10
425
gq9c ky26jo
10 Mar 21
Business combination disclosure
4:40pm
DEFA14A
cx5if3iuskh3
10 Feb 21
Additional proxy soliciting materials
8:21am
DEFM14A
ohco9jxg
9 Feb 21
Proxy related to merger
4:55pm
425
1wbq o5bb93k21022q6g
8 Feb 21
Business combination disclosure
4:17pm
8-K
itx0k rrc
8 Feb 21
Entry into a Material Definitive Agreement
4:14pm
425
d7c 4c1bagh7rlzl
11 Jan 21
Business combination disclosure
9:26am
8-K
w15fnbwzq8v3l4
11 Jan 21
Corporate Presentation January 2021
8:45am
425
2tqos9hb
30 Dec 20
Business combination disclosure
4:09pm
8-K
axcup7o8
30 Dec 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
425
8nmxs4 t2hk5bdg
11 Dec 20
Business combination disclosure
6:02am
8-K
81ntp 7au
11 Dec 20
Entry into a Material Definitive Agreement
6:01am
425
jlmsjmd730q3qm9f6ij
10 Dec 20
Business combination disclosure
9:45am
8-K
heue q5yssgs2lk94
10 Dec 20
Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue1 Specialty Pharmaceutical Company
8:21am
8-K
5zv geq1ojcx6057to
9 Nov 20
Neos Therapeutics Reports Third Quarter 2020 Financial Results
7:29am
8-K
tasa7we0rdxuyuy4xcq
10 Aug 20
Neos Therapeutics Reports Second Quarter 2020 Financial Results
7:11am
8-K
fajb1vouhzo11xe
19 Jun 20
Departure of Directors or Certain Officers
5:05pm
8-K
gwxnzv7
11 Jun 20
Entry into a Material Definitive Agreement
4:21pm
8-K
pcdi403ujedo
3 Jun 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am